Asunto(s)
Antiinflamatorios/administración & dosificación , Dolor de la Región Lumbar/tratamiento farmacológico , Metilprednisolona/análogos & derivados , Radiculopatía/tratamiento farmacológico , Procedimientos Innecesarios , Antiinflamatorios/efectos adversos , Antiinflamatorios/uso terapéutico , Contraindicaciones , Humanos , Enfermedad Iatrogénica , Inyecciones Epidurales , Inyecciones Espinales/efectos adversos , Metilprednisolona/administración & dosificación , Metilprednisolona/efectos adversos , Metilprednisolona/uso terapéutico , Acetato de MetilprednisolonaRESUMEN
Based on the available evidence, the Therapeutics and Technology Assessment subcommittee concluded that 1) epidural steroid injections may result in some improvement in radicular lumbosacral pain when assessed between 2 and 6 weeks following the injection, compared to control treatments (Level C, Class I-III evidence). The average magnitude of effect is small and generalizability of the observation is limited by the small number of studies, highly selected patient populations, few techniques and doses, and variable comparison treatments; 2) in general, epidural steroid injection for radicular lumbosacral pain does not impact average impairment of function, need for surgery, or provide long-term pain relief beyond 3 months. Their routine use for these indications is not recommended (Level B, Class I-III evidence); 3) there is insufficient evidence to make any recommendation for the use of epidural steroid injections to treat radicular cervical pain (Level U).